
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $49.9M | $102.6M | $115.4M | $130.4M | $113.7M | |
Revenue Growth (YoY) | 231.18% | 105.47% | 12.45% | 13% | -12.8% | |
Cost of Revenues | $63M | $95M | $97.5M | $101.4M | $75.1M | |
Gross Profit | -$13M | $7.6M | $17.8M | $29M | $38.6M | |
Gross Profit Margin | -26.11% | 7.42% | 15.46% | 22.24% | 33.92% | |
R&D Expenses | $28.9M | $36.7M | $48.9M | $57.3M | $38.4M | |
Selling, General & Admin | $75.6M | $101.4M | $130M | $141.5M | $113.5M | |
Other Inc / (Exp) | -$1.7M | -- | -$1.4M | -- | -$2.7M | |
Operating Expenses | $104.4M | $138.1M | $178.9M | $198.8M | $151.9M | |
Operating Income | -$117.5M | -$130.5M | -$161M | -$169.8M | -$113.4M | |
Net Interest Expenses | $2.4M | $1.2M | $275K | $2.5M | $14.1M | |
EBT. Incl. Unusual Items | -$121.5M | -$131.7M | -$162.7M | -$172.3M | -$127.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $199K | $295K | $523K | $491K | |
Net Income to Company | -$121.5M | -$131.9M | -$163M | -$172.8M | -$128M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$121.5M | -$131.9M | -$163M | -$172.8M | -$128M | |
Basic EPS (Cont. Ops) | -$72.75 | -$43.35 | -$50.70 | -$52.20 | -$36.90 | |
Diluted EPS (Cont. Ops) | -$72.75 | -$43.35 | -$50.70 | -$52.20 | -$36.90 | |
Weighted Average Basic Share | $1.1M | $3M | $3.2M | $3.3M | $3.5M | |
Weighted Average Diluted Share | $1.1M | $3M | $3.2M | $3.3M | $3.5M | |
EBITDA | -$115.4M | -$124.9M | -$153.9M | -$153.8M | -$97.9M | |
EBIT | -$118.6M | -$130M | -$159.1M | -$159.6M | -$103.6M | |
Revenue (Reported) | $49.9M | $102.6M | $115.4M | $130.4M | $113.7M | |
Operating Income (Reported) | -$117.5M | -$130.5M | -$161M | -$169.8M | -$113.4M | |
Operating Income (Adjusted) | -$118.6M | -$130M | -$159.1M | -$159.6M | -$103.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $22.9M | $30.6M | $33.5M | $28.2M | $29.8M | |
Revenue Growth (YoY) | 218.72% | 33.31% | 9.55% | -15.83% | 5.62% | |
Cost of Revenues | $22.6M | $26.1M | $27M | $20M | $18.7M | |
Gross Profit | $289K | $4.4M | $6.4M | $8.2M | $11.1M | |
Gross Profit Margin | 1.26% | 14.54% | 19.21% | 29.16% | 37.19% | |
R&D Expenses | $7.6M | $10.8M | $13.8M | $12.6M | $5.5M | |
Selling, General & Admin | $22.4M | $30.1M | $36.1M | $32.5M | $22M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$7.7M | |
Operating Expenses | $30M | $40.9M | $49.9M | $45.1M | $27.5M | |
Operating Income | -$29.7M | -$36.5M | -$43.5M | -$36.9M | -$16.4M | |
Net Interest Expenses | $310K | $302K | $294K | $2.9M | $1.6M | |
EBT. Incl. Unusual Items | -$30M | -$36.8M | -$43.8M | -$39.8M | -$25.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $39K | $115K | $192K | $162K | $115K | |
Net Income to Company | -$30M | -$36.9M | -$44M | -$39.9M | -$25.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$30M | -$36.9M | -$44M | -$39.9M | -$25.8M | |
Basic EPS (Cont. Ops) | -$10.50 | -$11.70 | -$13.50 | -$11.77 | -$3.66 | |
Diluted EPS (Cont. Ops) | -$10.50 | -$11.70 | -$13.50 | -$11.77 | -$3.66 | |
Weighted Average Basic Share | $2.9M | $3.2M | $3.3M | $3.4M | $7M | |
Weighted Average Diluted Share | $2.9M | $3.2M | $3.3M | $3.4M | $7M | |
EBITDA | -$28.3M | -$35.1M | -$39.5M | -$32.4M | -$20.8M | |
EBIT | -$29.6M | -$36.4M | -$40.8M | -$33.8M | -$22.1M | |
Revenue (Reported) | $22.9M | $30.6M | $33.5M | $28.2M | $29.8M | |
Operating Income (Reported) | -$29.7M | -$36.5M | -$43.5M | -$36.9M | -$16.4M | |
Operating Income (Adjusted) | -$29.6M | -$36.4M | -$40.8M | -$33.8M | -$22.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $65.7M | $110.2M | $118.3M | $125.1M | $115.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $74.8M | $98.5M | $98.5M | $94.3M | $73.9M | |
Gross Profit | -$9.2M | $11.8M | $19.8M | $30.8M | $41.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $30.6M | $40M | $51.8M | $56.1M | $31.3M | |
Selling, General & Admin | $87.2M | $109.1M | $136M | $137.8M | $103M | |
Other Inc / (Exp) | -$1.8M | -- | -- | -- | -$7.7M | |
Operating Expenses | $117.7M | $149.1M | $187.8M | $194M | $134.3M | |
Operating Income | -$126.9M | -$137.3M | -$168M | -$163.2M | -$92.9M | |
Net Interest Expenses | $2.1M | $1.2M | $267K | $5.1M | $12.8M | |
EBT. Incl. Unusual Items | -$130.8M | -$138.5M | -$169.7M | -$168.3M | -$113.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $39K | $275K | $372K | $493K | $444K | |
Net Income to Company | -$130.9M | -$138.8M | -$170M | -$168.8M | -$113.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$130.9M | -$138.8M | -$170M | -$168.8M | -$113.8M | |
Basic EPS (Cont. Ops) | -$83.39 | -$44.40 | -$52.95 | -$50.77 | -$29.16 | |
Diluted EPS (Cont. Ops) | -$83.39 | -$44.40 | -$52.95 | -$50.77 | -$29.16 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$124.4M | -$131.6M | -$158.3M | -$146.7M | -$86.3M | |
EBIT | -$128.5M | -$136.8M | -$163.6M | -$152.6M | -$91.9M | |
Revenue (Reported) | $65.7M | $110.2M | $118.3M | $125.1M | $115.3M | |
Operating Income (Reported) | -$126.9M | -$137.3M | -$168M | -$163.2M | -$92.9M | |
Operating Income (Adjusted) | -$128.5M | -$136.8M | -$163.6M | -$152.6M | -$91.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $22.9M | $30.6M | $33.5M | $28.2M | $29.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $22.6M | $26.1M | $27M | $20M | $18.7M | |
Gross Profit | $289K | $4.4M | $6.4M | $8.2M | $11.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $7.6M | $10.8M | $13.8M | $12.6M | $5.5M | |
Selling, General & Admin | $22.4M | $30.1M | $36.1M | $32.5M | $22M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$7.7M | |
Operating Expenses | $30M | $40.9M | $49.9M | $45.1M | $27.5M | |
Operating Income | -$29.7M | -$36.5M | -$43.5M | -$36.9M | -$16.4M | |
Net Interest Expenses | $310K | $302K | $294K | $2.9M | $1.6M | |
EBT. Incl. Unusual Items | -$30M | -$36.8M | -$43.8M | -$39.8M | -$25.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $39K | $115K | $192K | $162K | $115K | |
Net Income to Company | -$30M | -$36.9M | -$44M | -$39.9M | -$25.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$30M | -$36.9M | -$44M | -$39.9M | -$25.8M | |
Basic EPS (Cont. Ops) | -$10.50 | -$11.70 | -$13.50 | -$11.77 | -$3.66 | |
Diluted EPS (Cont. Ops) | -$10.50 | -$11.70 | -$13.50 | -$11.77 | -$3.66 | |
Weighted Average Basic Share | $2.9M | $3.2M | $3.3M | $3.4M | $7M | |
Weighted Average Diluted Share | $2.9M | $3.2M | $3.3M | $3.4M | $7M | |
EBITDA | -$28.3M | -$35.1M | -$39.5M | -$32.4M | -$20.8M | |
EBIT | -$29.6M | -$36.4M | -$40.8M | -$33.8M | -$22.1M | |
Revenue (Reported) | $22.9M | $30.6M | $33.5M | $28.2M | $29.8M | |
Operating Income (Reported) | -$29.7M | -$36.5M | -$43.5M | -$36.9M | -$16.4M | |
Operating Income (Adjusted) | -$29.6M | -$36.4M | -$40.8M | -$33.8M | -$22.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $295M | $182.3M | $73.2M | $68.5M | $124M | |
Short Term Investments | $19.9M | $157.1M | $214.3M | $134.8M | $34.7M | |
Accounts Receivable, Net | $6.5M | $25.6M | $28.1M | $33M | $35.6M | |
Inventory | $18.4M | $39.2M | $51.5M | $49.2M | $59.4M | |
Prepaid Expenses | $6.2M | -- | -- | -- | -- | |
Other Current Assets | -- | $5.5M | $6.6M | $5.7M | $4.5M | |
Total Current Assets | $345.9M | $409.8M | $373.6M | $291.2M | $258.2M | |
Property Plant And Equipment | $23.3M | $20.2M | $22M | $18.6M | $12.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $34.7M | $33.5M | $4.5M | $3.9M | $5.5M | |
Total Assets | $403.8M | $463.5M | $400.1M | $313.8M | $275.8M | |
Accounts Payable | $4.9M | $1.8M | $603K | $5.8M | $3.9M | |
Accrued Expenses | $9.4M | $13.5M | $12.7M | $11.4M | $7.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $882K | $1.2M | $1.3M | $1.6M | $1.8M | |
Other Current Liabilities | $1.4M | $4M | $7.1M | $5.8M | $3.1M | |
Total Current Liabilities | $36.7M | $51.7M | $51.9M | $55.3M | $45.4M | |
Long-Term Debt | $29.7M | $29.8M | $96.3M | $130.1M | $197.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $75.2M | $89.4M | $154.1M | $190.9M | $249M | |
Common Stock | $43K | $47K | $48K | $50K | $53K | |
Other Common Equity Adj | $1K | -$184K | -$564K | $68K | $42K | |
Common Equity | $328.6M | $374.1M | $246M | $122.9M | $26.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $328.6M | $374.1M | $246M | $122.9M | $26.8M | |
Total Liabilities and Equity | $403.8M | $463.5M | $400.1M | $313.8M | $275.8M | |
Cash and Short Terms | $314.9M | $339.5M | $287.5M | $203.3M | $158.7M | |
Total Debt | $29.7M | $29.8M | $96.3M | $130.1M | $197.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $251.8M | $114.3M | $36.4M | $32.2M | $75.9M | |
Short Term Investments | $25.7M | $187.9M | $212.8M | $194.7M | $113.1M | |
Accounts Receivable, Net | $12.1M | $26.9M | $34.3M | $36.5M | $36.9M | |
Inventory | $24.6M | $42.9M | $47.7M | $55.8M | $55.8M | |
Prepaid Expenses | $7.6M | $5.4M | -- | -- | -- | |
Other Current Assets | -- | -- | $6M | $6.2M | $4.9M | |
Total Current Assets | $321.7M | $377.4M | $337.3M | $325.4M | $286.6M | |
Property Plant And Equipment | $23.6M | $20.8M | $21M | $17M | $10.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $34.6M | $33.5M | $4.4M | $3.9M | $4.1M | |
Total Assets | $379.8M | $431.7M | $362.7M | $346.2M | $301.2M | |
Accounts Payable | $6.7M | $5.1M | $2M | $6.8M | $1.2M | |
Accrued Expenses | $8.7M | $16.1M | $12.2M | $9.9M | $7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $984K | $1.2M | $1.4M | $1.6M | $1.9M | |
Other Current Liabilities | $2.3M | $6.1M | $5.3M | $5.2M | $2.7M | |
Total Current Liabilities | $34.8M | $48.9M | $44.3M | $50.7M | $34.2M | |
Long-Term Debt | $29.7M | $29.8M | $96.5M | $196.8M | $94.1M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $73.2M | $86.3M | $146.4M | $253M | $131.3M | |
Common Stock | $43K | $48K | $49K | $52K | $3.9M | |
Other Common Equity Adj | -$8K | -$649K | -$113K | -$258K | $88K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | $161.9M | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $306.6M | $345.5M | $216.3M | $93.2M | $169.9M | |
Total Liabilities and Equity | $379.8M | $431.7M | $362.7M | $346.2M | $301.2M | |
Cash and Short Terms | $277.5M | $302.3M | $249.2M | $226.9M | $189M | |
Total Debt | $29.7M | $29.8M | $96.5M | $196.8M | $94.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$121.5M | -$131.9M | -$163M | -$172.8M | -$128M | |
Depreciation & Amoritzation | $3.2M | $5.2M | $5.2M | $5.8M | $5.7M | |
Stock-Based Compensation | $21.4M | $17.4M | $27.2M | $38.6M | $29.4M | |
Change in Accounts Receivable | -$2.6M | -$19.1M | -$2.5M | -$5.1M | -$5M | |
Change in Inventories | -$16.3M | -$22M | -$14.7M | $1.6M | -$10.9M | |
Cash From Operations | -$99M | -$130.3M | -$145.7M | -$131.4M | -$116.3M | |
Capital Expenditures | $9.1M | $3.1M | $8.3M | $3.4M | $912K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $3.9M | -$142.5M | -$66.3M | $83M | $103.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $29.6M | -- | $96.1M | $33.2M | $66.5M | |
Long-Term Debt Repaid | -$31M | -- | -$31.2M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$938K | |
Cash From Financing | $385.7M | $160.1M | $72.9M | $43.7M | $67.9M | |
Beginning Cash (CF) | $37.7M | $328.3M | $215.7M | $76.5M | $71.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $290.6M | -$112.6M | -$139.1M | -$4.7M | $55.5M | |
Ending Cash (CF) | $328.3M | $215.7M | $76.5M | $71.8M | $127.3M | |
Levered Free Cash Flow | -$108.1M | -$133.4M | -$154.1M | -$134.8M | -$117.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$30M | -$36.9M | -$44M | -$39.9M | -$25.8M | |
Depreciation & Amoritzation | $1.2M | $1.3M | $1.4M | $1.5M | $1.3M | |
Stock-Based Compensation | $5.9M | $5M | $8.5M | $8.2M | $3M | |
Change in Accounts Receivable | -$5.6M | -$1.3M | -$6.2M | -$3.5M | -$1.5M | |
Change in Inventories | -$7.2M | -$4.2M | $2.9M | -$7M | $3.7M | |
Cash From Operations | -$38.6M | -$38.3M | -$44.8M | -$45.9M | -$25.7M | |
Capital Expenditures | $919K | $1.5M | $810K | $354K | $123K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$6.8M | -$33.4M | $2.6M | -$59M | -$78.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $66.5M | $98.3M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$205M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $2.2M | $3.7M | $5.3M | $68.6M | $55.7M | |
Beginning Cash (CF) | $328.3M | $215.7M | $76.5M | $71.8M | $127.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$43.2M | -$68M | -$36.8M | -$36.3M | -$48.1M | |
Ending Cash (CF) | $285.1M | $147.7M | $39.7M | $35.5M | $79.3M | |
Levered Free Cash Flow | -$39.5M | -$39.8M | -$45.6M | -$46.3M | -$25.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$130.9M | -$138.8M | -$170M | -$168.8M | -$113.8M | |
Depreciation & Amoritzation | $4.1M | $5.2M | $5.3M | $5.9M | $5.6M | |
Stock-Based Compensation | $26.7M | $16.6M | $30.7M | $38.3M | $24.1M | |
Change in Accounts Receivable | -$5.2M | -$14.8M | -$7.4M | -$2.4M | -$3M | |
Change in Inventories | -$24.4M | -$19M | -$7.7M | -$8.2M | -$185K | |
Cash From Operations | -$112.7M | -$130M | -$152.2M | -$132.5M | -$96.1M | |
Capital Expenditures | $7.2M | $3.7M | $7.7M | $3M | $681K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$22M | -$169.1M | -$30.3M | $21.4M | $84.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $99.7M | $98.3M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $261.1M | $161.7M | $74.5M | $107M | $54.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $126.4M | -$137.4M | -$108M | -$4.2M | $43.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$120M | -$133.7M | -$159.8M | -$135.5M | -$96.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$30M | -$36.9M | -$44M | -$39.9M | -$25.8M | |
Depreciation & Amoritzation | $1.2M | $1.3M | $1.4M | $1.5M | $1.3M | |
Stock-Based Compensation | $5.9M | $5M | $8.5M | $8.2M | $3M | |
Change in Accounts Receivable | -$5.6M | -$1.3M | -$6.2M | -$3.5M | -$1.5M | |
Change in Inventories | -$7.2M | -$4.2M | $2.9M | -$7M | $3.7M | |
Cash From Operations | -$38.6M | -$38.3M | -$44.8M | -$45.9M | -$25.7M | |
Capital Expenditures | $919K | $1.5M | $810K | $354K | $123K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$6.8M | -$33.4M | $2.6M | -$59M | -$78.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $66.5M | $98.3M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$205M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $2.2M | $3.7M | $5.3M | $68.6M | $55.7M | |
Beginning Cash (CF) | $328.3M | $215.7M | $76.5M | $71.8M | $127.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$43.2M | -$68M | -$36.8M | -$36.3M | -$48.1M | |
Ending Cash (CF) | $285.1M | $147.7M | $39.7M | $35.5M | $79.3M | |
Levered Free Cash Flow | -$39.5M | -$39.8M | -$45.6M | -$46.3M | -$25.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.